ChemKAS Pharmaceutics Ltd
Registered number: 14301201
Balance Sheet
as at 31 August 2024
2024 2023
£ £
Current assets
Cash at bank and in hand 100 100
100 100
Capital and reserves
Called up share capital 100 100
Shareholders' funds 100 100
The directors are satisfied that the company is entitled to exemption from the requirement to obtain an audit under section 480 of the Companies Act 2006 relating to dormant companies.
Members have not required the company to obtain an audit in accordance with section 476 of the Act.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
The accounts have been prepared and delivered in accordance with the special provisions applicable to companies subject to the small companies regime. A profit and loss account has not been delivered to the Registrar of Companies.
Abid Khan
Director
Approved by the board on 20 September 2024
ChemKAS Pharmaceutics Ltd
Notes to the Accounts
for the year ended 31 August 2024
1 Accounting policies
The accounts have been prepared under the historical cost convention.
2 Other information
ChemKAS Pharmaceutics Ltd is a private company limited by shares and incorporated in England. Its registered office is:
2nd Floor Daisy Building
Castle Hill Hospital, Castle Road,
Cottingham
United Kingdom
HU16 5JQ
ChemKAS Pharmaceutics Ltd 14301201 true 2023-09-01 2024-08-31 2024-08-31 VT Final Accounts October 2023 release 2 Abid Khan No description of principal activity 14301201 core:ShareCapital 2023-08-31 14301201 2023-09-01 2024-08-31 14301201 bus:EntityNoLongerTradingButTradedInPast 2023-09-01 2024-08-31 14301201 bus:PrivateLimitedCompanyLtd 2023-09-01 2024-08-31 14301201 bus:AuditExemptWithAccountantsReport 2023-09-01 2024-08-31 14301201 bus:Director40 2023-09-01 2024-08-31 14301201 countries:England 2023-09-01 2024-08-31 14301201 bus:FRS102 2023-09-01 2024-08-31 14301201 bus:FullAccounts 2023-09-01 2024-08-31 14301201 2024-08-31 14301201 core:ShareCapital 2024-08-31 14301201 2023-08-31 iso4217:GBP